Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation

Mutat Res. 1998 Jul 17;403(1-2):85-94. doi: 10.1016/s0027-5107(98)00055-4.

Abstract

3SB, a mouse thymoma cell line, is one of the most radio-sensitive cells (D0 = 0.3 Gy), and its rapid apoptosis (4 h after 5 Gy irradiation, 90% apoptosis) seems to play a decisive role in enhancing the radiosensitivity. To understand the molecular mechanisms underlying extremely high radiosensitivity and rapid apoptosis, we attempted to isolate X-ray-resistant (XR) variants from 3SBH5, a stable subclone of 3SB, by repeating exposure of the cells to 2-5 Gy X-rays. Four independent stable XR variants, R111, R223, R316 and R429, were isolated by the repeated irradiation protocols. All XR cells possessed about 3 times higher D10 values than that of their parental 3SBH5. They were also resistant to apoptosis; only 10% cells underwent apoptosis 4 h after 5 Gy irradiation. The p53 protein was induced in all the cell lines after 5 Gy X-irradiation. These variants showed a cross resistance to a chemical reagent daunorubicin (DNR) that is known to be involved in the ceramide-mediated apoptosis. DNR, as well as C2-ceramide (5 muM) induced apoptosis in parental 3SBH5 cell, but not in two XR variants, R233 and R316 cells. Present result suggests that the induction of X-ray resistance by repeated X-irradiation might be achieved, at least partly, by the enhanced resistance to the ceramide-mediated apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / genetics*
  • Apoptosis / radiation effects*
  • Daunorubicin / pharmacology
  • Drug Resistance / genetics
  • Genetic Variation
  • Methyl Methanesulfonate / pharmacology
  • Mice
  • Mitomycin / pharmacology
  • Mutagens / pharmacology
  • Radiation Tolerance / genetics*
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism
  • Thymoma / drug therapy
  • Thymoma / genetics*
  • Thymoma / pathology
  • Thymoma / radiotherapy*
  • Thymus Neoplasms / drug therapy
  • Thymus Neoplasms / genetics*
  • Thymus Neoplasms / pathology
  • Thymus Neoplasms / radiotherapy*
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 / biosynthesis

Substances

  • Antineoplastic Agents
  • Mutagens
  • N-acetylsphingosine
  • Tumor Suppressor Protein p53
  • Mitomycin
  • Methyl Methanesulfonate
  • Sphingosine
  • Daunorubicin